Mesalazine

3 trials 2 recruiting AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

3 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 1

Indications tested

Colitis ulcerative 1

Sponsors using this IMP

Faes Farma S.A. 1 Grupo Espanol De Trabajo En Enfermedad De Crohn y Colitis Ulcerosa 1 Karolinska Institutet 1

All trials

3 total

Immunosuppressant Discontinuation in Elderly patients with ulcerative colitis And long-term remission Pending

2025-524675-23-00 Phase IV 1 country Grupo Espanol De Trabajo En Enfermedad De Crohn y Colitis Ulcerosa
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with a… Recruiting

2023-509606-30-00 Phase III 7 countries Faes Farma S.A.
Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting

2024-514765-19-01 Phase II 2 countries Karolinska Institutet

Showing 1–3 of 3 trials

← All drugs A–Z